title: Positive feedback effect of oestradiol in superovulated women.
abstract: To investigate the mechanism of blockage of the luteinizing hormone (LH) surge in superovulated women, six normally ovulating women were studied in three cycles: a spontaneous cycle treated with exogenous oestrogen (oestradiol benzoate cycle), a cycle treated with follicle stimulating hormone (FSH; 225 IU/day; FSH cycle) and a cycle treated with FSH plus exogenous oestrogen (FSH + oestradiol benzoate cycle). Oestradiol benzoate was injected i.m. on cycle days 4 (0800 and 2000 h), 5 (0800 h) and 6 (0800 h) at doses of 0.5, 1.0, 2.0 and 2.5 mg respectively to achieve supraphysiological levels of serum oestradiol. Exogenous oestrogen (supraphysiological oestradiol levels) induced an LH surge in all six women in the oestradiol benzoate cycles, but failed to stimulate an LH surge in three of the six patients during treatment with FSH. In three patients treated with FSH, an LH surge was stimulated both by supraphysiological (FSH + oestradiol benzoate cycles) and 'high normal' oestradiol levels (FSH cycles), while in three patients treated with FSH only, the LH surge was blocked, although the threshold level for the positive feedback effect had been exceeded by cycle day 9. We conclude that in women, supraphysiological concentrations of oestradiol exert a positive feedback effect on LH secretion. It is suggested that the occurrence of an LH surge in cycles superovulated with FSH is not dependent on serum oestradiol concentrations, but mainly on the strength of ovarian inhibitory substances.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Ioannina, Greece.
authors.forename: I E
authors.initials: IE
authors.lastname: Messinis
authors.forename: I
authors.initials: I
authors.lastname: Mademtzis
authors.forename: K
authors.initials: K
authors.lastname: Zikopoulos
authors.forename: E
authors.initials: E
authors.lastname: Tsahalina
authors.forename: K
authors.initials: K
authors.lastname: Seferiadis
authors.forename: O
authors.initials: O
authors.lastname: Tsolas
authors.forename: A A
authors.initials: AA
authors.lastname: Templeton
mesh_terms: D004958:Estradiol / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D005246:Feedback / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000494:pharmacology; D005498:Follicular Phase / Q000187:drug effects; D006801:Humans; D007273:Injections, Intramuscular; D007986:Luteinizing Hormone / Q000097:blood; D010902:Pituitary Gland / Q000378:metabolism; D011374:Progesterone / Q000097:blood; D013480:Superovulation / Q000187:drug effects*
chemical_list: D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone